{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-final-clinical-study-report-csr-preparation”
},
“headline”: “SOP for Final Clinical Study Report (CSR) Preparation”,
“description”: “This SOP establishes procedures for preparing the Final Clinical Study Report (CSR) in compliance with ICH E3, FDA, EMA, CDSCO, and WHO guidelines. It covers data integration, statistical analysis, medical writing, QC, approvals, and regulatory submission of CSRs.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 23/12/2025
Standard Operating Procedure for Final Clinical Study Report (CSR) Preparation
| SOP No. | CR/OPS/102/2025 |
| Supersedes | NA |
| Page No. | 1 of 47 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define the process for preparing the Final Clinical Study Report (CSR) according to
Scope
This SOP applies to sponsors, CROs, medical writers, statisticians, investigators, and QA teams involved in CSR preparation. It covers CSR drafting, data integration, statistical analysis, medical writing, review, approval, submission, and archiving.
Responsibilities
- Sponsor: Oversees CSR preparation, ensures compliance, and approves final report.
- Medical Writer: Drafts CSR based on data listings, tables, and figures.
- Statistician: Provides statistical analysis outputs and interpretation.
- QA: Conducts quality control and ensures adherence to ICH E3.
- Regulatory Affairs: Submits CSR to authorities and registers results on clinical trial registries.
Accountability
The Sponsor is accountable for ensuring the CSR is complete, accurate, and compliant with regulatory standards. The Medical Writing Lead is accountable for coordinating report drafting and integration of multidisciplinary inputs.
Procedure
1. CSR Planning
1.1 Develop CSR Preparation Plan including timelines and responsibilities.
1.2 Define CSR template aligned with ICH E3 requirements.
1.3 Maintain CSR Preparation Log (Annexure-1).
2. Data Integration
2.1 Lock database prior to CSR preparation.
2.2 Extract and validate data listings, tables, and figures.
2.3 Ensure consistency between CSR and Clinical Database Lock Documentation.
3. CSR Drafting
3.1 Medical writer drafts CSR including methodology, efficacy, safety, and statistical sections.
3.2 Include appendices: protocol, amendments, sample CRFs, patient listings, and monitoring reports.
3.3 Document draft version in CSR Draft Log (Annexure-2).
4. Review and QC
4.1 Internal cross-functional review (Medical, Biostatistics, QA, Regulatory).
4.2 QA performs QC for accuracy, formatting, and compliance with ICH E3.
4.3 Review comments documented in CSR Review Log (Annexure-3).
5. Approval
5.1 Obtain sponsor sign-off prior to submission.
5.2 Document approvals in CSR Approval Log (Annexure-4).
6. Submission and Disclosure
6.1 Submit CSR to FDA, EMA, CDSCO, or other applicable agencies.
6.2 Post results on ClinicalTrials.gov, EU CTR, or WHO ICTRP as required.
6.3 Maintain Submission Log (Annexure-5).
7. Archiving
7.1 Archive CSR, draft versions, and approval documentation in TMF.
7.2 Ensure retention per global guidelines.
Abbreviations
- SOP: Standard Operating Procedure
- CSR: Clinical Study Report
- QA: Quality Assurance
- CRO: Contract Research Organization
- TMF: Trial Master File
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
- CDSCO: Central Drugs Standard Control Organization
- WHO: World Health Organization
Documents
- CSR Preparation Log (Annexure-1)
- CSR Draft Log (Annexure-2)
- CSR Review Log (Annexure-3)
- CSR Approval Log (Annexure-4)
- Submission Log (Annexure-5)
References
- ICH E3 – Clinical Study Reports
- FDA – Clinical Study Report Guidance
- EMA – CSR Submission Requirements
- CDSCO – Clinical Study Report Rules
- WHO – Clinical Study Transparency
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Medical Writer |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Operations |
Annexures
Annexure-1: CSR Preparation Log
| Date | Activity | Responsible | Status |
|---|---|---|---|
| 01/09/2025 | CSR Preparation Plan finalized | Medical Writer | Completed |
Annexure-2: CSR Draft Log
| Date | Draft Version | Prepared By | Remarks |
|---|---|---|---|
| 10/09/2025 | v0.1 | Medical Writer | Initial draft circulated |
Annexure-3: CSR Review Log
| Date | Reviewer | Section | Comments | Status |
|---|---|---|---|---|
| 15/09/2025 | Statistician | Results | Clarify subgroup analysis | Resolved |
Annexure-4: CSR Approval Log
| Date | Approved By | Designation | Decision |
|---|---|---|---|
| 20/09/2025 | Sponsor Clinical Head | VP Clinical Development | Approved |
Annexure-5: Submission Log
| Date | Agency | Submission Type | Submitted By |
|---|---|---|---|
| 25/09/2025 | FDA | CSR Submission | Regulatory Affairs |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Operations |
For more SOPs visit: Pharma SOP